Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002284
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Study of Azidothymidine AZT in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Pilot Study To Evaluate Azidothymidine AZT in the Treatment of Human Immunodeficiency Virus HIV Infection in Patients Receiving a Bone Marrow Transplant
Status:
COMPLETED
Status Verified Date:
1995-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine whether zidovudine AZT in conjunction with bone marrow transplantation prevents the reinfection of donor hematopoieticlymphoid cells in patients with positive HTLV III antibody and large celldiffuse histiocytic lymphoma Patients who are candidates will be evaluated for HTLV III activity and drug levels
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 006 | None | None | None |